Despite multiple attempts; Takeda still manages to keep Uloric on the market
This page features: Cited Research Articles Uloric, the common brand name for the medication Febuxostat, manufactured by Takeda Pharmaceuticals, entered the US market in 2009. Uloric is a pill that is advertised to manage gout, a condition that approximately 8.3 million people in the United States suffer from. Gout is a type of arthritis that causes …
Despite multiple attempts; Takeda still manages to keep Uloric on the market Read More »